The structure of myristoyl-CoA:protein N-myristoyltransferase

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1441, Issue 2-3, 1999, Pages 162-172

  Bhatnagar, Rajiv S ^a   Fütterer, Klaus ^a   Waksman, Gabriel ^a   Gordon, Jeffrey I ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acyl CoA recognition; Acyltransferase; Enzyme mechanism; GCN5; Oxyanion hole; Protein N myristoylation

Indexed keywords

ACYL COENZYME A; PROTEIN N MYRISTOYLTRANSFERASE; SC 58272; UNCLASSIFIED DRUG;

ENZYME BINDING; ENZYME MECHANISM; ENZYME STRUCTURE; ENZYME SUBSTRATE COMPLEX; MYRISTYLATION; PRIORITY JOURNAL; PROTEIN FAMILY; REVIEW; SACCHAROMYCES CEREVISIAE;

ACYLTRANSFERASES; AMINO ACID SEQUENCE; ANIMALS; CATALYSIS; HUMANS; KINETICS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PROTEIN CONFORMATION; PROTEIN FOLDING; SUBSTRATE SPECIFICITY;

EUKARYOTA; SACCHAROMYCES CEREVISIAE;

EID: 0345533863     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1388-1981(99)00155-9     Document Type: Review

References (20)

1. Boutin J.A. Myristoylation. Cell. Signal. 9:1997;15-35.
2. Resh M.D. Regulation of cellular signalling by fatty acid acylation and prenylation of signal transduction proteins. Cell. Signal. 8:1997;403-412.
3. Peitzsch R.M., McLaughlin S. Binding of acylated peptides and fatty acids to phospholipid vesicles: pertinence to myristoylated proteins. Biochemistry. 32:1993;10436-10443.
4. McLaughlin S., Aderem A. The myristoyl-electrostatic switch: a modulator of reversible protein-membrane interactions. Trends Biochem. Sci. 20:1995;272-276.
5. Murray D., Hermida-Matsumoto L., Buser C.A., Tsang J., Sigal C.T., Ben-Tal N., Honig B., Resh M.D., McLaughlin S. Electrostatics and the membrane association of Src: theory and experiment. Biochemistry. 37:1998;2145-2149.
6. Zozulya S., Stryer L. Calcium-myristoyl protein switch. Proc. Natl. Acad. Sci. USA. 89:1992;11569-11573.
7. Ames J.B., Tanaka T., Ikura M., Stryer L. Nuclear magnetic resonance evidence for Ca(2+)-induced extrusion of the myristoyl group of recoverin. J. Biol. Chem. 270:1995;30909-30913.
8. Ames J.B., Ishima R., Tanaka T., Gordon J.I., Stryer L., Ikura M. Molecular mechanics of calcium-myristoyl switches. Nature. 389:1997;198-202.
9. Goldberg J. Structural basis for activation of ARF GTPase: mechanisms of guanine nucleotide exchange and GTP-myristoyl switching. Cell. 95:1998;237-248.
10. Rudnick D.A., McWherter C.A., Rocque W.J., Lennon P.J., Getman D.P., Gordon J.I. Kinetic and structural evidence for a sequential ordered Bi Bi mechanism of catalysis by Saccharomyces cerevisiae myristoyl-CoA:protein N-myristoyltransferase. J. Biol. Chem. 266:1991;9732-9739.
11. Sikorski J.A., Devadas B., Zupec M.E., Freeman S.K., Brown D.L., Lu H.F., Nagarajan S., Mehta P.P., Wade A.C., Kishore N.S., Bryant M.L., Getman D.P., McWherter C.A., Gordon J.I. Selective peptidic and peptidomimetic inhibitors of Candida albicans myristoylCoA:protein N-myristoyltransferase: a new approach to antifungal therapy. Biopolymers. 43:1997;43-71.
12. Devadas B., Freeman S.K., McWherter C.A., Kishore N.S., Lodge J.K., Jackson-Machelski E., Gordon J.I., Sikorski J.A. Novel biologically active nonpeptidic inhibitors of myristoylCoA:protein N-myristoyltransferase. J. Med. Chem. 41:1998;996-1000.
13. Lodge J.K., Jackson-Machelski E., Higgins M., McWherter C.A., Sikorski J.A., Devadas B., Gordon J.I. Genetic and biochemical studies establish that the fungicidal effect of a fully depeptidized inhibitor of Cryptococcus neoformans myristoyl-CoA:protein N-myristoyltransferase (Nmt) is Nmt-dependent. J. Biol. Chem. 273:1998;12482-12491.
14. Weston S.A., Camble R., Colls J., Rosenbrock G., Taylor I., Egerton M., Tucker M.D., Tunnicliffe A., Mistry A., Mancia F., de la Fortelle E., Irwin J., Bricogne G., Pauptit R.A. Crystal structure of the anti-fungal target N-myristoyl transferase. Nat. Struct. Biol. 5:1998;213-221.
15. Paige L.A., Zheng G.-Q., DeFrees S.A., Cassady J.M., Geahlen R.L. S-(2-Oxopentadecyl)-CoA, a nonhydrolyzable analogue of myristoyl-CoA, is a potent inhibitor of myristoyl-CoA:protein N-myristoyltransferase. J. Med. Chem. 32:1989;1665-1667.
16. Bhatnagar R.S., Schall O.F., Jackson-Machelski E., Sikorski J.A., Devadas B., Gokel G.W., Gordon J.I. Titration calorimetric analysis of AcylCoA recognition by myristoylCoA:protein N-myristoyltransferase. Biochemistry. 36:1997;6700-6708.
17. Devadas B., Zupec M.E., Freeman S.K., Brown D.L., Nagarajan S., Sikorski J.A., McWherter C.A., Getman D.P., Gordon J.I. Design and syntheses of potent and selective dipeptide inhibitors of Candida albicans myristoyl-CoA:protein N-myristoyltransferase. J. Med. Chem. 38:1995;1837-1840.
18. Bhatnagar R.S., Fütterer K., Farazi T.A., Korolev S., Murray C.L., Jackson-Machelski E., Gokel G.W., Gordon J.I., Waksman G. Structure of N-myristoyltransferase with bound myristoylCoA and peptide substrate analogs. Nat. Struct. Biol. 5:1998;1091-1097.
19. Dutnall R.N., Tafrov S.T., Sternglanz R., Ramakrishnan V. Structure of the histone acetyltransferase Hat1: a paradigm for the GCN5-related N-acetyltransferase superfamily. Cell. 94:1998;427-438.
20. Wolf E., Vassilev A., Makino Y., Sali A., Nakatani Y., Burley S.K. Crystal structure of a GCN5-related N-acetyltransferase: Serratia marcescens aminoglycoside 3-N-acetyltransferase. Cell. 94:1998;439-449.